TFF2 and stroke disorder: Taken together, these findings suggest that neurogenic inflammation occurs following ischemic stroke and may contribute to the increased BBB permeability and elevated ICP observed, suggesting that blocking the action of SP with a tachykinin NK1-r antagonist may be an effective strategy to mitigate these post-stroke complications and thus improve outcome.